Page 839 - Hematology_ Basic Principles and Practice ( PDFDrive )

723.e2 Part VI Non-Malignant Leukocytes

in Europe: Entering a new century, do we do better? J Allergy Clin 67. Lohr NJ, Molleston JP, Strauss KA, et al: Human ITCH E3 ubiquitin
Immunol 602–610, 2010. ligase deficiency causes syndromic multisystem autoimmune disease.
45. Greil J, Rausch T, Giese T, et al: Whole-exome sequencing links caspase Am J Hum Genet 86(3):447–453, 2010.
recruitment domain 11 (CARD11) inactivation to severe combined 68. Lopez-Herrera G, Tampella G, Pan-Hammarström Q, et al: Deleteri-
immunodeficiency. J Allergy Clin Immunol 131(5):1376–1383.e3, ous mutations in LRBA are associated with a syndrome of immune
2013. deficiency and autoimmunity. Am J Hum Genet 90(6):986–1001, 2012.
46. Grimbacher B, Hutloff A, Schlesier M, et al: Homozygous loss of ICOS 69. Lucas CL, Zhang Y, Venida A, et al: Heterozygous splice mutation in
is associated with adult-onset common variable immunodeficiency. Nat PIK3R1 causes human immunodeficiency with lymphoproliferation
Immunol 4(3):261–268, 2003. due to dominant activation of PI3K. J Exp Med 211(13):2537–2547,
47. Hacein-Bey-Abina S, Le Deist F, Carlier F, et al: Sustained correction of 2014.
X-linked severe combined immunodeficiency by ex vivo gene therapy. 70. Lucas CL, Kuehn HS, Zhao F, et al: Dominant-activating germline
N Engl J Med 346(16):1185–1193, 2002. mutations in the gene encoding the PI(3)K catalytic subunit p110δ
48. Hacein-Bey-Abina S, Kalle Von C, Schmidt M, et al: LMO2-associated result in T cell senescence and human immunodeficiency. Nat Immunol
clonal T cell proliferation in two patients after gene therapy for SCID- 15(1):88–97, 2014.
X1. Science 302(5644):415–419, 2003. 71. Macchi P, Villa A, Giliani S, et al: Mutations of Jak-3 gene in patients
49. Hacein-Bey-Abina S, Gaspar HB, Blondeau J, et al: Outcomes Follow- with autosomal severe combined immune deficiency (SCID). Nature
ing Gene Therapy in Patients With Severe Wiskott-Aldrich Syndrome. 377(6544):65–68, 1995.
JAMA 313(15):1550, 2015. 72. Markert ML, Devlin BH, McCarthy EA: Thymus transplantation. Clin
50. Hacein-Bey-Abina S, Pai S-Y, Gaspar HB, et al: A Modified γ-Retrovirus Immunol 135(2):236–246, 2010.
Vector for X-Linked Severe Combined Immunodeficiency. N Engl J 73. Martin E, Palmic N, Sanquer S, et al: CTP synthase 1 deficiency in
Med 371(15):1407–1417, 2014. humans reveals its central role in lymphocyte proliferation. Nature
51. Hanson EP, Monaco-Shawver L, Solt LA, et al: Hypomorphic nuclear 2014.
factor-kappaB essential modulator mutation database and reconstitu- 74. Massaad MJ, Ramesh N, Geha RS: Wiskott-Aldrich syndrome: a
tion system identifies phenotypic and immunologic diversity. J Allergy comprehensive review. Ann N Y Acad Sci 1285:26–43, 2013.
Clin Immunol 122(6):1169–1177, 2008. 75. McDonald-McGinn DM, Sullivan KE: Chromosome 22q11.2 deletion
52. Hoernes M, Seger R, Reichenbach J: Modern management of primary syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine
B-cell immunodeficiencies. Pediatr Allergy Immunol 22(8):758–769, (Baltimore) 90(1):1–18, 2011.
2011. 76. McKinnon ML, Rozmus J, Fung S-Y, et al: Combined immunodefi-
53. Holland SM, DeLeo FR, Elloumi HZ, et al: STAT3 mutations in the ciency associated with homozygous MALT1 mutations. J Allergy Clin
hyper-IgE syndrome. N Engl J Med 357(16):1608–1619, 2007. Immunol 133(5):1458–1462, 1462.e1–7, 2014.
54. Howe SJ, Mansour MR, Schwarzwaelder K, et al: Insertional muta- 77. Moratto D, Giliani S, Bonfim C, et al: Long-term outcome and lineage-
genesis combined with acquired somatic mutations causes leukemo- specific chimerism in 194 patients with Wiskott-Aldrich syndrome
genesis following gene therapy of SCID-X1 patients. J Clin Invest treated by hematopoietic cell transplantation in the period 1980-
118(9):3143–3150, 2008. 2009: an international collaborative study. Blood 118(6):1675–1684,
55. Huck K, Feyen O, Niehues T, et al: Girls homozygous for an IL- 2011.
2-inducible T cell kinase mutation that leads to protein deficiency 78. Nadeau K, Hwa V, Rosenfeld RG: STAT5b deficiency: an unsuspected
develop fatal EBV-associated lymphoproliferation. J Clin Invest cause of growth failure, immunodeficiency, and severe pulmonary
119(5):1350–1358, 2009. disease. J Pediatr 158(5):701–708, 2011. [Epub 2011 Mar 17]; Review.
56. Jabara HH, Ohsumi T, Chou J, et al: A homozygous mucosa-associated Erratum in: J Pediatr 159(2):356, 2011.
lymphoid tissue 1 (MALT1) mutation in a family with combined 79. Nagamine K, Peterson P, Scott HS, et al: Positional cloning of the
immunodeficiency. J Allergy Clin Immunol 132(1):151–158, 2013. APECED gene. Nat Genet 17(4):393–398, 1997.
57. Kisand K, Peterson P: Autoimmune polyendocrinopathy candidiasis 80. Nehme NT, Pachlopnik Schmid J, Debeurme F, et al: MST1 muta-
ectodermal dystrophy: known and novel aspects of the syndrome. Ann tions in autosomal recessive primary immunodeficiency characterized
N Y Acad Sci 1246(1):77–91, 2011. by defective naive T-cell survival. Blood 119(15):3458–3468, 2012.
58. Kohn DB, Pai S-Y, Sadelain M: Gene therapy through autologous 81. Neven B, Leroy S, Decaluwe H, et al: Long-term outcome after hemato-
transplantation of gene-modified hematopoietic stem cells. Biol Blood poietic stem cell transplantation of a single-center cohort of 90 patients
Marrow Transplant 19(1 Suppl):S64–S69, 2013. with severe combined immunodeficiency. Blood 113(17):4114–4124,
59. Korthäuer U, Graf D, Mages HW, et al: Defective expression of T-cell 2009.
CD40 ligand causes X-linked immunodeficiency with hyper-IgM. 82. Nichols KE, Harkin DP, Levitz S, et al: Inactivating mutations in an
Nature 361(6412):539–541, 1993. SH2 domain-encoding gene in X-linked lymphoproliferative syndrome.
60. Kracker S, Gardes P, Mazerolles F, et al: Immunoglobulin class switch Proc Natl Acad Sci USA 95(23):13765–13770, 1998.
recombination deficiencies. Clin Immunol 135(2):193–203, 2010. 83. Noguchi M, Yi H, Rosenblatt HM, et al: Interleukin-2 receptor gamma
61. Kuehn HS, Ouyang W, Lo B, et al: Immune dysregulation in human chain mutation results in X-linked severe combined immunodeficiency
subjects with heterozygous germline mutations in CTLA4. Science in humans. Cell 73(1):147–157, 1993.
345(6204):1623–1627, 2014. 84. Notarangelo LD, Roifman CM, Giliani S: Cartilage-hair hypoplasia:
62. Kuehn HS, Niemela JE, Rangel-Santos A, et al: Loss-of-function of the molecular basis and heterogeneity of the immunological phenotype.
protein kinase C (PKC) causes a B-cell lymphoproliferative syndrome Curr Opin Allergy Clin Immunol 8(6):534–539, 2008.
in humans. Blood 121(16):3117–3125, 2013. 85. Ochs HD, Filipovich AH, Veys P, et al: Wiskott-Aldrich syndrome:
63. Kung C, Pingel JT, Heikinheimo M, et al: Mutations in the tyrosine diagnosis, clinical and laboratory manifestations, and treatment. Biol
phosphatase CD45 gene in a child with severe combined immunode- Blood Marrow Transplant 15(1 Suppl):84–90, 2008.
ficiency disease. Nat Med 6(3):343–345, 2000. 86. Oliveira JB, Bleesing JJ, Dianzani U, et al: Revised diagnostic criteria
64. Kwan A, Abraham RS, Currier R, et al: Newborn screening for severe and classification for the autoimmune lymphoproliferative syndrome
combined immunodeficiency in 11 screening programs in the United (ALPS): report from the 2009 NIH International Workshop. Blood
States. JAMA 312(7):729–738, 2014. 116(14):e35–e40, 2010.
65. Liu L, Okada S, Kong X-F, et al: Gain-of-function human STAT1 87. Oliveira JB, Fleisher TA: 26. Laboratory evaluation of primary
mutations impair IL-17 immunity and underlie chronic mucocutane- immunodeficiencies. J Allergy Clin Immunol 2(Suppl 2):S297–S305,
ous candidiasis. J Exp Med 208(8):1635–1648, 2011. 2009.
66. Lo B, Zhang K, Lu W, et al: AUTOIMMUNE DISEASE. Patients 88. Pai S-Y, Logan BR, Griffith LM, et al: Transplantation Outcomes
with LRBA deficiency show CTLA4 loss and immune dysregulation for Severe Combined Immunodeficiency, 2000–2009. N Engl J Med
responsive to abatacept therapy. Science 349(6246):436–440, 2015. 371(5):434–446, 2014.